Suanfarma

  • Suanfarma CDMO – Cipan Site (Portugal)
  • Suanfarma CDMO – Rovereto Site (Italy)
About Suanfarma

Suanfarma is a B2B life sciences company dedicated to health and innovation. It develops, manufactures, and distributes high-quality pharmaceutical ingredients sustainably. With 10 global offices, it serves 400+ customers in 70+ countries, offering customized solutions throughout drug development. Through Suanfarma CDMO, it provides end-to-end services, combining bioconversion via fermentation and chemical synthesis to produce complex molecules at scale, optimizing supply chains with quality, efficiency, and sustainability.

 

Certifications
  • Country/Region:
    Spain
  • On CPHI since:
    2015
  • Certificates:
    3
  • Employees:
    250 - 499
Company types
CMO/CDMO
Distributor/Import Export
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Contact info
Meet us at

CPHI & PMEC China 2026

Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Suanfarma (10)

  • LYMECYCLINE

    Product LYMECYCLINE

    Lymecycline is a second-generation oral tetracycline prodrug known for its broad-spectrum activity against both Gram-positive and Gram-negative bacteria. It is widely used in the treatment of acne and other susceptible bacterial infections, particularly where good tolerability is essential.
  • RIBOCICLIB
  • TIAMULIN
  • CANAGLIFLOZIN
  • MUPIROCIN

    Product MUPIROCIN

    Mupirocin is an antibiotic active pharmaceutical ingredient (API) used in formulations for the treatment of bacterial skin infections caused by susceptible Gram-positive bacteria, including Staphylococcus aureus. At Suanfarma, we supply high-quality Mupirocin API to support pharmaceutical development and m...
  • TAZOBACTAM

    Product TAZOBACTAM

    Tazobactam is a β-lactamase inhibitor active pharmaceutical ingredient (API) used in combination with certain β-lactam antibiotics to enhance their activity against resistant bacteria. At Suanfarma, we supply high-quality Tazobactam API to support the development and manufacturing of reliable pharmaceutica...
  • TAZOBACTAM + PIPERACILLIN

    Product TAZOBACTAM + PIPERACILLIN

    Piperacillin + Tazobactam is a combination of a broad-spectrum β-lactam antibiotic and a β-lactamase inhibitor active pharmaceutical ingredients (APIs). This combination enhances antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria by protecting piperacillin from enzymati...

Suanfarma Resources (4)

  • News Suanfarma and the Fight Infections Foundation: a strategic collaboration to advance global health

    Suanfarma has initiated a collaboration with the Fight Infections Foundation, an internationally renowned organization with more than three decades of scientific leadership in the study, prevention, and treatment of infectious diseases. This alliance is born from a shared vision: combining capabilities and exploring ways of working together to contribute to global health.
  • Video Revolutionizing Pharma Manufacturing With TT&GO® Technology Transfer

    In the rapidly evolving landscape of pharmaceutical manufacturing, the TT&GO® platform by Suanfarma CDMO stands out as a revolutionary solution for technology transfer. This session will explore into the unique methodology of TT&GO®, which integrates rigorous, systematic procedures grounded in risk-based analysis to facilitate seamless technology transfers. Methodological rigor and flexibility: Understanding the systematic approach of TT&GO® that applies to various phases of the product lifecycle, ensuring adaptability and compliance with Good Manufacturing Practices (GMP). Risk management and cost efficiency: Analyzing how TT&GO®'s proactive risk assessment and mitigation strategies lead to reduced failure rates and cost savings, empowering clients to pursue ambitious project timelines with minimized risks. Real-world applications and outcomes: Presenting case studies and success stories of TT&GO® in action, highlighting the platform's impact on accelerating commercial launches and enhancing market competitiveness. Attendees of this session can expect to leave with a comprehensive understanding of how advanced technology transfer methodologies like TT&GO® can be leveraged to optimize pharmaceutical manufacturing processes, ensuring higher efficiency, reduced risk, and better overall outcomes.
  • News Suanfarma Appoints Pere Mañé as New CEO to Drive Industrial Growth and Global Expansion

    Suanfarma has announced the appointment of Pere Mañé Godina as its new Chief Executive Officer (CEO). This marks the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion
  • Video Suanfarma, At the Core of a Better Life

    Suanfarma is a key player in the life sciences sector, specializing in the development of active pharmaceutical ingredients (APIs) and contract development and manufacturing (CDMO) services. Since 1993, Suanfarma has been dedicated to enhancing global health by improving access to affordable medicines. We operate advanced facilities in Portugal and Italy, and supports over 400 laboratories worldwide through a robust network of 12 commercial offices.

    Suanfarma’s proprietary APIs are developed using cutting-edge techniques, including AI and Flow Chemistry, ensuring high standards and GMP compliance. We are committed to sustainability and global health, offering innovative solutions for High Potency APIs and expanding fermentation and chemical synthesis capacities to meet growing global demand. 

    Our customer-centric approach and strong focus on quality makes us a trusted partner in the pharmaceutical industry.

    ...